Induction of autophagy contributes to the myocardial protection of valsartan against ischemia-reperfusion injury

Molecular Medicine Reports

Volumn 8, Issue 6, 2013, Pages 1824-1830

  Wu, Xiaoqian ^a   He, Lishan ^a   Cai, Yi ^a   Zhang, Guiping ^a   He, Yulian ^a   Zhang, Zhijia ^a   He, Xiaoen ^a   He, Yanhua ^a   Zhang, Genshui ^a   Luo, Jiandong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AKT; Autophagy; Ischemia reperfusion injury; MTOR; Valsartan

Indexed keywords

3 METHYLADENINE; BECLIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; S6 KINASE; VALSARTAN; 3-METHYLADENINE; ADENINE; CARDIOTONIC AGENT; TARGET OF RAPAMYCIN KINASE; TETRAZOLE DERIVATIVE; VALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CAROTID ARTERY LIGATION; CONTROLLED STUDY; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART PROTECTION; HISTOLOGY; ISCHEMIC PRECONDITIONING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; HEART MUSCLE; HEMODYNAMICS; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ADENINE; ANIMALS; AUTOPHAGY; CARDIOTONIC AGENTS; HEMODYNAMICS; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TETRAZOLES; TOR SERINE-THREONINE KINASES; VALINE;

EID: 84893801180     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1708     Document Type: Article

References (31)

1. Tritto I, Zuchi C, Vitale S and Ambrosio G: Therapy against reperfusion-induced microvascular injury. Curr Pharm Des 19: 4586-4596, 2013.
2. Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F and Pedrinelli R: Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 198: 22-28, 2008.
3. Varagic J, Frohlich ED, Susic D, et al: AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol Heart Circ Physiol 294: H853-H858, 2008.
4. Yang J, Jiang H, Yang J, Ding JW, Chen LH, Li S and Zhang XD: Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Mol Cell Biochem 330: 39-46, 2009.
5. Sawicki G, Menon V and Jugdutt BI: Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade. J Card Fail 10: 442-449, 2004.
6. Iekushi K, Taniyama Y, Azuma J, et al: Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension 49: 1409-1414, 2007.
7. Kundu M and Thompson CB: Autophagy: basic principles and relevance to disease. Annu Rev Pathol 3: 427-455, 2008.
8. Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell 132: 27-42, 2008.
9. Oka T, Hikoso S, Yamaguchi O, et al: Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485: 251-255, 2012.
10. Ma X, Liu H, Foyil SR, et al: Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 125: 3170-3181, 2012.
11. Buss SJ, Muenz S, Riffel JH, et al: Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 54: 2435-2446, 2009.
12. Marin TM, Keith K, Davies B, et al: Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest 121: 1026-1043, 2011.
13. Sala-Mercado JA, Wider J, Undyala VV, et al: Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation 122: S179-S184, 2010.
14. Zhai P, Sciarretta S, Galeotti J, Volpe M and Sadoshima J: Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion. Circ Res 109: 502-511, 2011.
15. Wu X, Cheng J, Li P, et al: Mechano-sensitive transcriptional factor Egr-1 regulates insulin-like growth factor-1 receptor expression and contributes to neointima formation in vein grafts. Arterioscler Thromb Vasc Biol 30: 471-476, 2010.
16. Wu X, Huang H, Tang F, Le K, Xu S and Liu P: Regulated expression of endothelial lipase in atherosclerosis. Mol Cell Endocrinol 315: 233-238, 2010.
17. Mizushima N: Autophagy: process and function. Genes Dev 21: 2861-2873, 2007.
18. Wang P, Guan YF, Du H, Zhai QW, Su DF and Miao CY: Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy 8: 77-87, 2012.
19. Gustafsson AB and Gottlieb RA: Autophagy in ischemic heart disease. Circ Res 104: 150-158, 2009.
20. Matsui Y, Takagi H, Qu X, et al: Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100: 914-922, 2007.
21. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB amd Kondo Y: Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72: 29-39, 2007.
22. Shinojima N, Yokoyama T, Kondo Y and Kondo S: Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3: 635-637, 2007.
23. Ganley IG, Lam du H, Wang J, Ding X, Chen S and Jiang X: ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 284: 12297-12305, 2009.
24. Kim J, Kundu M, Viollet B and Guan KL: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13: 132-141, 2011.
25. Egan DF, Shackelford DB, Mihaylova MM, et al: Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456-461, 2011.
26. Stephan JS, Yeh YY, Ramachandran V, Deminoff SJ and Herman PK: The Tor and PKA signaling pathways independently target the Atg1/Atg13 protein kinase complex to control autophagy. Proc Natl Acad Sci USA 106: 17049-17054, 2009.
27. Nicklin P, Bergman P, Zhang B, et al: Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136: 521-534, 2009.
28. Yu L, McPhee CK, Zheng L, et al: Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 465: 942-946, 2010.
29. Zou M, Lu N, Hu C, et al: Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell Signal 24: 1722-1732, 2012.
30. Zou Z, Wu L, Ding H, et al: MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J Biol Chem 287: 4148-4156, 2012.
31. Ugland H, Naderi S, Brech A, Collas P and Blomhoff HK: cAMP induces autophagy via a novel pathway involving ERK, cyclin E and Beclin 1. Autophagy 7: 1199-1211, 2011.